Cibc World Market Inc. Novo Nordisk A S Transaction History

Cibc World Market Inc.

$48 Billion
Q3 2024

A detailed history of Cibc World Market Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Cibc World Market Inc. holds 619,774 shares of NVO stock, worth $67.6 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

619,774

Previous 499,396 24.1%

Holding current value

$67.6 Million

Previous $71.3 Million 3.52%

% of portfolio

0.15%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$119.07 - $145.42 $14.3 Million - $17.5 Million	120,378 Added 24.1%	619,774 $73.8 Million
Q2 2024 Aug 07, 2024	BUY	$122.71 - $146.91 $13.9 Million - $16.6 Million	113,136 Added 29.29%	499,396 $71.3 Million
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $3.66 Million - $4.87 Million	35,810 Added 10.22%	386,260 $49.6 Million
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $971,724 - $1.17 Million	-11,070 Reduced 3.06%	350,450 $36.3 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $17 Million - $37.4 Million	187,350 Added 107.57%	361,520 $32.9 Million
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $1.86 Million - $2.06 Million	-11,934 Reduced 6.41%	174,170 $28.2 Million
Q1 2023 May 12, 2023	BUY	$132.34 - $159.14 $4.19 Million - $5.04 Million	31,647 Added 20.49%	186,104 $29.6 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $4.38 Million - $5.78 Million	42,729 Added 38.24%	154,457 $20.9 Million
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $3.43 Million - $4.2 Million	-35,955 Reduced 24.35%	111,728 $11.1 Million
Q2 2022 Aug 10, 2022	BUY	$103.24 - $121.81 $1.42 Million - $1.68 Million	13,773 Added 10.29%	147,683 $16.5 Million
Q1 2022 May 12, 2022	SELL	$93.1 - $112.54 $1.62 Million - $1.96 Million	-17,405 Reduced 11.5%	133,910 $14.9 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $257,725 - $314,711	-2,688 Reduced 1.75%	151,315 $16.9 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $3.11 Million - $3.93 Million	36,833 Added 31.44%	154,003 $14.8 Million
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $422,469 - $529,241	-6,244 Reduced 5.06%	117,170 $9.82 Million
Q1 2021 May 11, 2021	BUY	$67.06 - $75.82 $1.31 Million - $1.48 Million	19,539 Added 18.81%	123,414 $8.32 Million
Q4 2020 Feb 08, 2021	BUY	$63.89 - $73.8 $863,345 - $997,259	13,513 Added 14.95%	103,875 $7.26 Million
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $289,025 - $318,658	-4,538 Reduced 4.78%	90,362 $6.27 Million
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $3.19 Million - $3.7 Million	-54,477 Reduced 36.47%	94,900 $6.21 Million
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $802,191 - $1.05 Million	-16,219 Reduced 9.79%	149,377 $8.99 Million
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $350,565 - $409,626	7,031 Added 4.43%	165,596 $9.59 Million
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $274,400 - $308,397	-5,772 Reduced 3.51%	158,565 $8.2 Million
Q2 2019 Aug 08, 2019	SELL	$46.79 - $52.47 $1.08 Million - $1.21 Million	-23,062 Reduced 12.31%	164,337 $8.39 Million
Q1 2019 May 09, 2019	BUY	$46.36 - $52.63 $2.82 Million - $3.2 Million	60,811 Added 48.04%	187,399 $9.8 Million
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $192,870 - $219,381	4,643 Added 3.81%	126,588 $5.83 Million
Q3 2018 Nov 09, 2018	BUY	$46.76 - $51.24 $359,724 - $394,189	7,693 Added 6.73%	121,945 $5.75 Million
Q2 2018 Aug 08, 2018	BUY	$44.29 - $50.42 $336,736 - $383,343	7,603 Added 7.13%	114,252 $5.27 Million
Q1 2018 May 18, 2018	BUY	$48.49 - $58.14 $5.17 Million - $6.2 Million	106,649 New	106,649 $5.25 Million

Others Institutions Holding NVO

# of Institutions

1,950

Shares Held

319M

Call Options Held

5.22M

Put Options Held

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Novo Nordisk A S Transaction History